Developments in polymeric devices for oral insulin delivery

Bibliography

• Foster DW. Diabetes mellitus. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, editors, Harrison's principles of internal medicine. 14th edition. McGraw-Hill, New York; 1998. p. 2060-80
   Google Scholar
• Kahn CR, Shechter Y. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman AG, Rall TW, Nies AS, Taylor P, edititors, The pharmacological basis of therapeutics. 8th edition. Pergamon Press, New York; 1991. p. 1463-95
   Google Scholar
• Kudva YC, Basu A, Jenkins GD, et al. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care 2005;28:10-4
   PubMed Web of Science ®Google Scholar
• Varshosaz J. Insulin delivery systems for controlling diabetes, recent patents on endocrine. Metab Immune Drug Discov 2007;1:25-40
   Google Scholar
• Carino GP, Mathiowit E. Oral insulin delivery. Adv Drug Deliv Rev 1999;35:249-57
   PubMed Web of Science ®Google Scholar
• Packhaeuser CB, Kissel T. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. J Control Rel 2007;123:131-40
   PubMed Web of Science ®Google Scholar
• Graf A, Ablinger E, Peters S, et al. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Inter J Pharm 2008;350(1-2):351-60
   PubMed Web of Science ®Google Scholar
• Damge C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988;37:246-51
   PubMed Web of Science ®Google Scholar
• Damge C, Vranckx H, Balschmidt P, Couvreur P. Poly(alkylcyanoacrylate) nanospheres for oral administration of insulin. J Pharm Sci 1997;86:1403-9
   PubMed Web of Science ®Google Scholar
• Radwant MA, Enein Hya. The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J Microencapsul 2002;19:225-35
   PubMed Web of Science ®Google Scholar
• Schwendeman SP, Cardamone M, Brandon MP, et al. Stability of proteins and their delivery from biodegradable polymer microspheres. In: Cohen S, Bernstein H, editors, Microparticulate systems for the delivery of proteins and vaccines. Marcel Dekker, New York; 1996. p. 1-50
   Google Scholar
• Lucke. A, Kiermaier J, Pferich AG. Peptide acylation by poly (α-hydroxy esters). Pharm Res 2002;19:175-81
   PubMed Web of Science ®Google Scholar
• Na DH, Youn YS, Lee SD, et al. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J Control Rel 2003;92:291-9
   PubMed Web of Science ®Google Scholar
• Brunner A, Mader K, Pferich AG. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm Res 1999;16:847-53
   PubMed Web of Science ®Google Scholar
• Krauland AH, Guggi D, Schnurch AB. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Rel 2004;95:547-55
   PubMed Web of Science ®Google Scholar
• Krauland AH, Schnurch AB. Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Eur J Pharm Biopharm 2004;57:181-7
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 1996;13:896-901
   PubMed Web of Science ®Google Scholar
• Ramadas M, Paul W, Dileep KJ, et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats. J Microencapsul 2000;17:405-11
   PubMed Web of Science ®Google Scholar
• Pan Y, Li YJ, Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002;249:139-47
   PubMed Web of Science ®Google Scholar
• Xiong XY, Li YP, Li ZL, et al. Vesicles from pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J Control Rel 2007;120:11-7
   PubMed Web of Science ®Google Scholar
• Xiong XY, Tam KC, Gan LH. Synthesis and aggregation behavior of pluronic F127/poly(lactic acid) block copolymers in aqueous solutions. Macromolecules 2003;36:9979-85
   Web of Science ®Google Scholar
• Xiong XY, Tam KC, Gan LH. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J Control Rel 2005;103:73-82
   PubMed Web of Science ®Google Scholar
• Xiong XY, Tam KC, Gan LH. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nanoparticles. J Control Rel 2005;108:263-70
   PubMed Web of Science ®Google Scholar
• Lueben HL, Bohner V, Perard D, et al. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. Int J Pharm 1996;141:39-52
   Google Scholar
• Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res 1992;9:283-90
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Dave AM, et al. Stimulus-responsive “smart” hydrogels as novel drug delivery systems. Drug Dev Ind Pharm 2002;28:957-74
   PubMed Web of Science ®Google Scholar
• Morishita M, Lowman AM, Takayama K, et al. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Rel 2002;81:25-32
   PubMed Web of Science ®Google Scholar
• Ranjha NM, Doelker E. pH-sensitive hydrogels for site-specific drug delivery. I. Swelling behaviour of crosslinked copolymers of acrylic and methacrylic acid. STP Pharma 1999;9:335-40
   Web of Science ®Google Scholar
• Lowman AM, Peppas NA. Design of oral delivery systems for peptides and proteins using complexation graft copolymer networks. In: Peppas NA, Mooney DJ, Mikos AG, Peppas LB, editors, Biomaterials carriers for drug delivery and scaffolds for tissue engineering. AlChE, New York; 1997. p. 21-3
   Google Scholar
• Lowman AM, Morishita M, Kajita M, et al. Oral delivery of insulin using pH-responsive complexation gels. J Pharm Sci 1999;88:933-7
   PubMed Web of Science ®Google Scholar
• Madsen F, Peppas NA. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials 1999;20:1701-8
   PubMed Web of Science ®Google Scholar
• Bai JP, Chang LL, Guo JH. Effect of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon. J Pharm Sci 1995;84:1291-4
   PubMed Web of Science ®Google Scholar
• Lueben HL, Bochard G, Verhoef JC, et al. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res 1995;12:1293-8
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Nakamura K, et al. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J Control Rel 2006;110:587-94
   PubMed Web of Science ®Google Scholar
• Lowman AM, Peppas NA. Analysis of the complexation/decomplexation phenomena in polyelectrolyte networks. Macromolecules 1997;30:4959-65
   Web of Science ®Google Scholar
• Nakamura K, MurraY RJ, Joseph JI, et al. Oral insulin delivery using P(MAA-g.-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Rel 2004;95:589-99
   PubMed Web of Science ®Google Scholar
• Aragoa MA, Ponchel G, Orecchioni AM, et al. Bioadhesive potential of gliadin nanoparticle systems. Eur J Pharm Sci 2000;11:333-41
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Peppas NA, et al. Mucosal insulin delivery systems based on complexation polymerhydrogels: effect of particle size on insulin parenteral absorption. J Control Rel 2004;97:115-24
   PubMed Web of Science ®Google Scholar
• Foss AC, Goto T, Morishita M, Peppas NA. Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm 2004;57:163-9
   PubMed Web of Science ®Google Scholar
• Chandy T, Sharma CP. Chitosan as a biomaterial. Biomater Art Cell Art Org 1990;18:1-24
   PubMed Web of Science ®Google Scholar
• Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and haemostatic potential. J Biomater Mater Res 1997;34:21-8
   PubMed Web of Science ®Google Scholar
• Smith J, Wood E, Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res 2004;21:43-9
   PubMed Web of Science ®Google Scholar
• Schipper NG, Olsson S, Hoogstraate JA, et al. Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997;14:923-9
   PubMed Web of Science ®Google Scholar
• Hari PR, Chandy T, Sharma CP. Chitosan/calcium alginate beads for oral delivery of insulin. J Appl Polym Sci 1996;59:1795-801
   Web of Science ®Google Scholar
• Yoshioka H, Hirano R, Shioya T, Kako M. Encapsulation of mammalian cells with chitosan-carboxy methylcellulose capsules. Biotechnol Bioeng 1990;35:66-72
   PubMed Web of Science ®Google Scholar
• Du J, Zhang S, Sun R, et al. Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. II. Release of albumin in vitro. J Biomed Mater Res B Appl Biomater 2005;72B:299-304
   Web of Science ®Google Scholar
• Hu Y, Jiang X, DingY, et al. Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles. Biomaterials 2002;23:3193-201
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J Biomed Mater Res B Appl Biomater 2006;76B:298-305
   Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. Interpolymer complex microparticles based on polymethacrylic acid-chitosan for oral insulin delivery. J Appl Polym Sci 2006;99:506-12
   Web of Science ®Google Scholar
• Michael H, Skovby B, Kops J. Preparation by suspension polymerization of porous beads for enzyme immobilization. J Appl Polym Sci 1990;39:169-77
   Web of Science ®Google Scholar
• Kriwet B, Walter E, Kissel T. Synthesis of bioadhesive poly(acrylic acid) nano and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Control Rel 1998;56:149-58
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Rel 2006;114:242-50
   PubMed Web of Science ®Google Scholar
• Xiong XY, Tam KC, Gan LH. Hydrolytic degradation of Pluronic F127/poly(lactic acid) block copolymer nanoparticles. Macromolecules 2004;37:3425-30
   Web of Science ®Google Scholar
• Gebhart CL, Sriadibhatla S, Vinogradov S, et al. Design and formulation of polyplexes based on pluronic–polyethyleneimine conjugates for gene transfer. Bioconjug Chem 2002;13:937-44
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Ono S, Narioka K, et al. Application of surface coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J Pharm Sci 1999;88:248-52
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, Fetouhb AI MI, Pferich AG. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J Control Rel 2005;106:241-52
   PubMed Web of Science ®Google Scholar
• Cheng K, Lim LY. Insulin-loaded calcium pectinate nanoparticles: effects of pectin molecular weight and formulation pH. Drug Dev Ind Pharm 2004;30:359-67
   PubMed Web of Science ®Google Scholar
• Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Rel 2007;117:163-70
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Souto EB, Ferreira DC. Insulin-loaded alginate microspheres for oral delivery – effect of polysaccharide reinforcement on physicochemical properties and release profile. Carbohydr Polym 2007;69:725-31
   Web of Science ®Google Scholar
• Reis CP, Ribeiro AJ, Houng S, et al. Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity. Eur J Pharm Sci 2007;30:392-7
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Jones GJR, Jain AK, et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Rel 2007;122:141-50
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Jones GJR, Yandrapu SK, et al. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Rel 2007;117:421-9
   PubMed Web of Science ®Google Scholar
• Jones GJR. Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium. J Drug Target 2004;12:113-23
   PubMed Web of Science ®Google Scholar
• Kennedy FP. Recent developments in insulin delivery techniques: current status and future potential. Drugs 1991;42:213-27
   PubMed Web of Science ®Google Scholar
• Marble A, Krall LP, Brandley RE, et al. Diabetes Mellitus. 12th edition. Lea and Febiger, Philadelphia
   Google Scholar
• Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997;14:556-67
   PubMed Web of Science ®Google Scholar
• Lovatt M, Cooper A, Camilleri P. Energetics of cyclodextrin-induced dissociation of insulin. Eur Biophys J 1996;24:354-7
   PubMed Web of Science ®Google Scholar
• Irie T, Uekama K. Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev 1999;36:101-23
   PubMed Web of Science ®Google Scholar
• Osterberg O, Ericson L, Ingwersen SH, et al. Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin. J Pharmacokinet Pharmacodyn 2003;30:221-35
   PubMed Web of Science ®Google Scholar